|
|
 |
|
Viewing report
|
|
|
|
IMS Pharma Pricing & Reimbursement Concise Guide Series Selected Asia-Pacific Countries & Australasia
IMS Health, Dec 2007, Pages: 126
The IMS Pricing & Reimbursement Concise Guide is firmly established as the definitive reference and training text for Pricing & Reimbursement professionals around the world.
This best-selling report provides up-to-date coverage of key developments in Pricing & Reimbursement, market access, cost containment, trade margins and health care systems in the different markets.
Building on the reputation of this international report, and providing you with expanded country coverage, IMS’ Pricing & Reimbursement publications would like to introduce their new Concise Guide Series.
This report focuses on Selected Asia Pacific countries & Australasia: Australasia, China, India, Japan, New Zealand, South Korea and Taiwan
The series continues to apply monograph treatment and consistent methodology provided in previous editions.
Each country follows a standard format to facilitate easy comparison and cross-referencing of data providing a unique analysis and interpretation of the complex web of pricing and reimbursement systems.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
IMS Pharma Pricing & Reimbursement Concise Guide Series The Americas
IMS Pharma Pricing & Reimbursement Concise Guide Series Central & Eastern Europe
IMS Pharmaceutical Pricing and Reimbursement: A Concise Guide 2007
Pricing & Reimbursement in Asia-Pacific
Pricing and Reimbursement in the United Arab Emirates
Pricing & Reimbursement - Seven Major Markets Update
Pricing and Reimbursement in Key Asia Pacific Markets
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
Special Report: Pharmaceutical Pricing and Reimbursement in Germany, 2008
Valuing Pharmaceutical Innovation: Pricing and Reimbursement for Innovative Therapies
Global Trends in Reimbursement of Medical Technology
Pricing & Reimbursement in Europe: Can the Drive for Cost Effectiveness Overcome Cost Containment?
|
|
|
|
